DAWN - CIK 0001845337
Day One Biopharmaceuticals, Inc. has filed 493 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (227 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-08-10 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-03 | - |